{"id":"W4411085883","doi":"10.1002/jha2.70072","title":"Final Results of a Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Alberta Cancer Foundation","funders":"National Cancer Institute; Gilead Sciences","keywords":"Daratumumab; Medicine; Pomalidomide; Internal medicine; Dexamethasone; Clinical endpoint; Multiple myeloma; Refractory (planetary science); Neutropenia; Adverse effect; Oncology; Phases of clinical research; Clinical trial; Lenalidomide; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003357563,0.001222849,0.001520542,0.0003095964,0.0003407094,0.001037103,0.0006704822,0.001090852,0.004341772],"category_scores_gemma":[0.001357455,0.0004053529,0.001474597,0.0002965898,0.0004577097,0.0006352345,0.0004114727,0.00240875,0.001028384],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006256191,"about_ca_system_score_gemma":0.001208789,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00035345,"about_ca_topic_score_gemma":0.001138435,"domain_scores_codex":[0.9993673,0.0003569739,0.0000324572,0.00008119421,0.00006716475,0.00009499638],"domain_scores_gemma":[0.9991977,0.0001370958,0.0001856074,0.00008083278,0.00007927796,0.0003195551],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7203075,0.04861473,0.01055474,0.001537969,0.004384527,0.0003762278,0.0003384205,0.002607487,0.02781157,0.0004284124,0.015695,0.1673433],"study_design_scores_gemma":[0.718012,0.2538664,0.01477459,0.0001057139,0.001216614,0.0003531803,0.00004594364,0.0006632691,0.00252744,0.0003744666,0.008028225,0.00003222185],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9703614,0.008500896,0.001430903,0.002158162,0.0003424383,0.007087857,0.005208026,0.0001988763,0.004711613],"genre_scores_gemma":[0.9685699,0.003563397,0.004898096,0.003048005,0.0004105826,0.006639568,0.008083778,0.00006193131,0.004724657],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004341772,"threshold_uncertainty_score":0.0177567,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03366329470104022,"score_gpt":0.3353164022583257,"score_spread":0.3016531075572854,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}